MELK and non-small cell lung carcinoma: Our findings clarified a KLF5/BBOX1-AS1/miR-27a-5p/MELK regulatory axis in NSCLC (Fig. 8f), offering a theoretical foundation for employing BBOX1-AS1 as a promising therapeutic target for NSCLC.